USAMRAA Awarded Mary Bird Perkins Cancer Center and LSU a $2.2 Million Research Contract

The U.S. Army Medical Research Acquisition Activity (USAMRAA) recently awarded Mary Bird Perkins Cancer Center and LSU (Ken Hogstrom, PI) a $2.2 million research contract to fund proton therapy research that could result in targeting cancer treatments more effectively. A major advantage of proton therapy comes from the possibility of delivering high radiation doses to a targeted tumor while sparing surrounding healthy tissues and organs. Additional work on bolus electron conformal therapy, a new electron beam technology for individualized treatment of skin cancers, is described in the recent issue of Mary Bird Perkins Perspective.